Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FGF12 antisense RNA 3 (FGF12-AS3)
- Target
- FGF12-AS3
- Molecular classification
- Other, Long noncoding RNA
01
Overview
FGF12 antisense RNA 3 (FGF12-AS3) is a non-protein-coding long noncoding RNA (lncRNA) gene expressed in humans. Its sequence is antisense to the FGF12 gene; however, there is no published evidence that it functions as a therapeutic target or is involved in disease, drug response, or as a biomarker. Its precise biological roles, molecular interactions, and disease relevance are currently unknown in the scientific literature. Note: This entry is likely incorrect as a therapeutic target; FGF12-AS3 is not established as a receptor, enzyme, transporter, or any classic drug target. Most available functional information concerns the protein-coding FGF12 gene, not FGF12-AS3. If you meant the protein-coding gene FGF12 or its protein product, clarification is needed, as results do not support FGF12-AS3 as a conventional therapeutic target.
- Other names
- FGF12-AS3FGF12 antisense RNA 3 (non-protein coding)
Beyond the preview
Go deeper on FGF12 antisense RNA 3 (FGF12-AS3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FGF12 antisense RNA 3 (FGF12-AS3).